As of 2025-12-28, the EV/EBITDA ratio of Adicet Bio Inc (ACET) is -0.40. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Adicet's latest enterprise value is 51.56 mil USD. Adicet's TTM EBITDA according to its financial statements is -128.05 mil USD. Dividing these 2 quantities gives us the above Adicet EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-12-26 | -0.40 |
| 2025-12-24 | -0.40 |
| 2025-12-23 | -0.36 |
| 2025-12-22 | -0.37 |
| 2025-12-19 | -0.37 |
| 2025-12-18 | -0.34 |
| 2025-12-17 | -0.34 |
| 2025-12-16 | -0.34 |
| 2025-12-15 | -0.37 |
| 2025-12-12 | -0.38 |
| 2025-12-11 | -0.40 |
| 2025-12-10 | -0.44 |
| 2025-12-09 | -0.42 |
| 2025-12-08 | -0.41 |
| 2025-12-05 | -0.42 |
| 2025-12-04 | -0.44 |
| 2025-12-03 | -0.42 |
| 2025-12-02 | -0.45 |
| 2025-12-01 | -0.51 |
| 2025-11-28 | -0.56 |
| 2025-11-26 | -0.50 |
| 2025-11-25 | -0.50 |
| 2025-11-24 | -0.51 |
| 2025-11-21 | -0.50 |
| 2025-11-20 | -0.47 |
| 2025-11-19 | -0.47 |
| 2025-11-18 | -0.50 |
| 2025-11-17 | -0.49 |
| 2025-11-14 | -0.57 |
| 2025-11-13 | -0.57 |
| 2025-11-12 | -0.60 |
| 2025-11-11 | -0.55 |
| 2025-11-10 | -0.57 |
| 2025-11-07 | -0.55 |
| 2025-11-06 | -0.59 |
| 2025-11-05 | -0.61 |
| 2025-11-04 | -0.61 |
| 2025-11-03 | -0.65 |
| 2025-10-31 | -0.68 |
| 2025-10-30 | -0.71 |
| 2025-10-29 | -0.68 |
| 2025-10-28 | -0.80 |
| 2025-10-27 | -0.86 |
| 2025-10-24 | -0.85 |
| 2025-10-23 | -0.81 |
| 2025-10-22 | -0.87 |
| 2025-10-21 | -0.88 |
| 2025-10-20 | -0.96 |
| 2025-10-17 | -0.97 |
| 2025-10-16 | -1.03 |